Skip to main content

What the FDA labels say about taking them together

Azathioprine and olsalazine

Azathioprine's FDA label of November 8, 2025 names olsalazine in its drug interactions section, and olsalazine's label names azathioprine too. The olsalazine label: “Azathioprine or 6-Mercaptopurine: Increased risk of blood dyscrasias; monitor complete blood cell counts and platelet counts.”

Check it at the source: the azathioprine FDA label on DailyMed (effective November 8, 2025, Sebela Pharmaceuticals Inc.); the olsalazine FDA label on DailyMed (effective May 15, 2026, Viatris Specialty LLC).

What does the azathioprine label say about olsalazine?

Azathioprine label, drug interactions

Use with Aminosalicylates: There is in vitro evidence that aminosalicylate derivatives (e.g., sulphasalazine, mesalazine, or olsalazine) inhibit the TPMT enzyme.

Source: FDA drug label (IMURAN), NDA016324 (Legacy), as published by Sebela Pharmaceuticals Inc., effective November 8, 2025 (SPL set 606101a0-6244-7eff-e053-2a91aa0acadd), via openFDA; the full label on DailyMed

What does the olsalazine label say about azathioprine?

Olsalazine label, drug interactions

Azathioprine or 6-Mercaptopurine: Increased risk of blood dyscrasias; monitor complete blood cell counts and platelet counts.

Source: FDA drug label (Dipentum), Viatris Specialty LLC, effective May 15, 2026 (SPL set 8512d0c6-db4e-4673-b3b4-28975c18413f), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

17Azathioprine generic labelers
0Olsalazine generic labelers
AzathioprineOlsalazine
Labeled forOrgan transplant rejection, Rheumatoid arthritisCrohn's disease and ulcerative colitis
Boxed warningYesNo
Pharmacy cost (NADAC)$0.124 per tablet 50 mg tablet$15.70 per capsule 250 mg capsule
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?